sexta-feira, 6 de novembro de 2026
PesquisarExplore
pt.VIA.NEWS
Via News Knowledge File

BlackRock, Inc.

organization80% conf.·synced Nov 6, 2026

Investment management firm

60
sourced metrics
713
relationships
20
stated objectives
6
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Price 52 Week Low
922.90USD
Nov 5, 2026reference only
Market Cap
181367432311USD
Nov 5, 2026reference only
Stock Return Ytd
7.9%
Nov 5, 2026reference only
Stock Price
1170.67USD
Nov 5, 2026reference only
Price 52 Week High
1224.37USD
Nov 5, 2026reference only
Total Assets
175875000000.0USD
Jun 30, 2026reference only
Eps
12.19USD_per_share
Jun 30, 2026reference only
Stockholders Equity
57613000000.0USD
Jun 30, 2026reference only
Cash
10492000000.0USD
Jun 30, 2026reference only
Shares Outstanding
154996807.0shares
Jun 30, 2026reference only
Revenue
7084000000.0USD
Jun 30, 2026reference only
Total Liabilities
111335000000.0USD
Jun 30, 2026reference only
Net Income
1914000000.0USD
Jun 30, 2026reference only
Operating Income
2461000000.0USD
Jun 30, 2026reference only
Capex
106000000.0USD
Mar 31, 2026reference only
Operating Cash Flow
-980000000.0USD
Mar 31, 2026reference only

Stated objectives

Generate $500 million in annual revenue from private markets for insurance

source
target: 500000000 by 2031-01-01 00:00:00stated

Generate $500 million in annual revenue from private markets for wealth

source
target: 500000000 by 2031-01-01 00:00:00stated

Generate $500 million in annual revenue from active ETFs

source
target: 500000000 by 2031-01-01 00:00:00stated

Cut about 250 employees, roughly 1% of global workforce, to keep resources aligned with company objectives and client needs

source
target: 250 employees stated

Achieve low-to-mid-teens earnings growth

source
target: 10-15 stated

Expand profit margins through management fee growth

source
stated

Maintain adjusted operating margin of 45% or greater

source
target: 45% or greater stated

Grow private markets to insurance, private markets to wealth, digital assets, and active ETFs each to $500 million in annual revenue

source
target: $500 million per initiative by 2030-01-01 00:00:00stated

Target $400 billion in gross private markets fundraising through 2030

source
target: 400 billion USD by 2030-01-01 00:00:00stated

Target mid-single-digit percentage increase in G&A and broadly flat headcount in 2026 after annualizing HPS and Preqin impacts

source
target: mid-single-digit % G&A increase; flat headcount by 2026-12-31 00:00:00stated

Relationship graph · 713 connections

subsidiary of
204
Developed by
140
Invested in
72
Employs
62
managed by
42
Covered by
30
Owns
29
headquartered in
27
Partners with
AcornsSecuritize
board member of
Hans Vestberg

Via News coverage

As Ações Da BlackRock Aumentam 11% Na Reta Final Da Sessão
May 27, 2022
As Ações Da BlackRock Saltam 5% Até Agora
March 9, 2022
As Ações Da BlackRock Science And Technology Trust Saltam 5%
February 1, 2022
As Ações Da BlackRock Science And Technology Trust Diminuem 5% Até Agora
January 24, 2022
As Ações Da BlackRock Science And Technology Trust Diminuem 5%
January 23, 2022
As Ações Da BlackRock Science And Technology Trust Diminuem 5%
January 21, 2022
This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,996
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,996 factos verificados com a fonte5,552 documentos-fonte arquivados
Consulte estes dados → isubstrate.com